ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 117

Using Goutpro to Make Medical Trainees Gout Pros- a Single Blinded Randomized Control Study

Linh Ngo1, Eric Miller2, Peter A. Valen3 and Alisa Duran4, 1Division of Rheumatology, University of Minnesota, Minneapolis, MN, 2Medicine, Hennepin County Medical Center, Minneapolis, MN, 3Rheumatology/ Dept of Medicine, University of Minnesota/Minneapolis VAMC, Minneapolis, MN, 4Department of Medicine, University of Minnesota, Minneapolis, MN

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: educational innovation, educational research, gout and technology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: ARHP Education Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout is the most common type of inflammatory arthritis in the U.S., affecting 4% of the population. Despite modern advancements and the availability of reference tools, the current care from primary care providers is felt to be suboptimal in the U.S. One barrier to improving care in gout includes limited education during medical training.

To address limited education during training, we developed a digital adjunctive teaching tool, GoutPro, on the topic of gout. Utilizing a clinically integrative model proposed by Khan et al, it takes into consideration different learning styles, current guidelines on gout, interactive activities and clinical problem solving. In our pilot study, we obtained positive subject feedback through survey. To assess objective trainee improvement of gout knowledge, a single-blinded randomized controlled study assessing knowledge prior to and after GoutPro intervention was conducted.

Methods: We recruited a total of 19 medical trainees from Hennepin County Medical Center to participate in our study. Trainees included medical students of MS 3-4 training levels and residents of PGY 1-4 training levels. All trainees registered via an online registration form and consent forms were signed digitally. Registered participants were randomized proportionally according to level of training into the control and the study group via a novel automated cloud based system to keep the investigators blinded. Correspondence with participants was also managed by the automated system. All participants were sent an e-mail with a link to a pre-test of 14 questions on crystalline arthropathy based on recommendations from the 2012 ACR Gout Guidelines and MKSAP 17. The study group was instructed to attend a live session led by the investigators that utilized GoutPro. The control group was provided both the ACR Guidelines and UpToDate reference articles on crystalline arthropathy for review. All participants received an identical post-test 27 days later to avoid coinciding with trainee change of rotations. 15 out of 19 subjects completed the post-test. Our primary outcome was difference in pre- and post-quiz scores between the control and study group. The StudentÕs t-test was used for analysis.

Results:

Average Scores

Control Group

(n=10)

Study Group

(n=5)

Pre-Quiz

38%

52%

Post-Quiz

41%

59%

% Improvement

3%

7%

Conclusion:

1) The study group had a slightly higher percent improved test scores (7%) compared to those in control group (3%). The results did not reach statistical significance due to the small study size (P=0.99).  

2) At baseline, medical trainees in the study demonstrated low knowledge on gout demonstrating the need for improved gout curriculum.

3) Future GoutPro studies with larger sample size from multiple centers will be needed.

4) Utilization of a novel cloud-based automated system to randomize and communicate with study subjects was an effective cost-efficient way to recruit, organize and manage study subjects while maintaining investigator blindness.


Disclosure: L. Ngo, None; E. Miller, None; P. A. Valen, None; A. Duran, None.

To cite this abstract in AMA style:

Ngo L, Miller E, Valen PA, Duran A. Using Goutpro to Make Medical Trainees Gout Pros- a Single Blinded Randomized Control Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/using-goutpro-to-make-medical-trainees-gout-pros-a-single-blinded-randomized-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-goutpro-to-make-medical-trainees-gout-pros-a-single-blinded-randomized-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology